Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinUlrike Harre, Georg Schett, Dan Georgess et al.|Journal of Clinical Investigation|2012Cited by 708
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Maria Gabriella Raimondo, Jochen Wacker et al.|Annals of the Rheumatic Diseases|2024Cited by 150
Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Ricardo Grieshaber‐Bouyer, Melanie Hagen et al.|Nature Medicine|2024Cited by 147
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune DiseaseMelanie Hagen, Ricardo Grieshaber‐Bouyer, Laura Bucci et al.|New England Journal of Medicine|2024Cited by 111
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Christina Bergmann, Fabian Müller et al.|The Lancet Rheumatology|2024Cited by 96